Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 58,242 Less Arrow 51,614 Less Arrow 45,123
Financial expenses 332 Less Arrow 114 Less Arrow 0
Earnings before taxes 3,832 Less Arrow 3,457 Less Arrow 3,110
EBITDA 4,610 Less Arrow 3,589 Less Arrow 3,424
Total assets 32,610 More Arrow 65,540 Less Arrow 40,908
Current assets 32,342 More Arrow 64,752 Less Arrow 40,389
Current liabilities 16,250 More Arrow 52,004 Less Arrow 30,019
Equity capital 16,360 Less Arrow 13,536 Less Arrow 10,889
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 9 Less Arrow 7 Equal arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% Less Arrow 20.7% More Arrow 26.6%
Turnover per employee 6,471 More Arrow 7,373 Less Arrow 6,446
Profit as a percentage of turnover 6.6% More Arrow 6.7% More Arrow 6.9%
Return on assets (ROA) 12.8% Less Arrow 5.4% More Arrow 7.6%
Current ratio 199.0% Less Arrow 124.5% More Arrow 134.5%
Return on equity (ROE) 23.4% More Arrow 25.5% More Arrow 28.6%
Change turnover 6,628 Less Arrow 6,491 Less Arrow -15,726
Change turnover % 13% More Arrow 14% Less Arrow -26%
Chg. No. of employees 2 Less Arrow 0 Less Arrow -1
Chg. No. of employees % 29% Less Arrow 0% Less Arrow -13%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.